How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016

<div>Yearly prevalence of use per 10,000 persons of intravitreal anti-VEGF or dexamethasone in the general population, grouped by region and calendar years (2010–2016). Error bars represent the Wilson score 95% confidence interval (with continuity correction) around prevalence estimates.</div>

BioMed Research International

fig2

Figure 2

Figure 2: How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016 

Figure 2 | How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016 